A detailed history of Abbot Financial Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Abbot Financial Management, Inc. holds 15,571 shares of ABBV stock, worth $2.73 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
15,571
Previous 15,686 0.73%
Holding current value
$2.73 Million
Previous $2.69 Million 14.28%
% of portfolio
1.58%
Previous 1.47%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $18,841 - $22,922
-115 Reduced 0.73%
15,571 $3.07 Million
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $80,490 - $93,995
-520 Reduced 3.21%
15,686 $2.69 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $61,920 - $69,736
-450 Reduced 2.7%
16,206 $2.51 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $66,795 - $77,325
-500 Reduced 2.91%
16,656 $2.48 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $66,255 - $82,450
-500 Reduced 2.83%
17,156 $2.31 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $28,922 - $33,308
-200 Reduced 1.12%
17,656 $2.81 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $125,308 - $150,278
-906 Reduced 4.83%
17,856 $2.89 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $429,472 - $492,576
-3,200 Reduced 14.57%
18,762 $2.52 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $27,524 - $34,992
-200 Reduced 0.9%
21,962 $3.36 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $72,589 - $90,062
-550 Reduced 2.42%
22,162 $3.59 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $15,040 - $19,030
-140 Reduced 0.61%
22,712 $3.08 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $10,640 - $12,078
100 Added 0.44%
22,852 $2.47 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $50,500 - $56,260
480 Added 2.16%
22,752 $2.56 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $40,920 - $45,048
400 Added 1.83%
22,272 $2.41 Million
Q4 2020

Feb 11, 2021

SELL
$80.49 - $108.67 $52,318 - $70,635
-650 Reduced 2.89%
21,872 $2.34 Million
Q3 2020

Oct 26, 2020

SELL
$85.91 - $100.83 $12,972 - $15,225
-151 Reduced 0.67%
22,522 $1.97 Million
Q2 2020

Jul 22, 2020

SELL
$73.37 - $98.18 $1,687 - $2,258
-23 Reduced 0.1%
22,673 $2.23 Million
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $12,900 - $19,558
-200 Reduced 0.87%
22,696 $1.73 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $90,451 - $113,173
1,254 Added 5.79%
22,896 $2.03 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $32,560 - $39,147
-517 Reduced 2.33%
21,642 $1.64 Million
Q2 2019

Aug 08, 2019

SELL
$65.7 - $83.98 $29,565 - $37,791
-450 Reduced 1.99%
22,159 $1.61 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $31,139 - $38,404
-400 Reduced 1.74%
22,609 $2.08 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $43,921 - $48,826
-494 Reduced 2.1%
23,009 $2.18 Million
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $26,934 - $31,869
-300 Reduced 1.26%
23,503 $2.18 Million
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $48,305 - $64,685
-525 Reduced 2.16%
23,803 $2.25 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $71,648 - $78,568
-800 Reduced 3.18%
24,328 $2.35 Million
Q3 2017

Oct 25, 2017

BUY
$69.85 - $89.22 $1.76 Million - $2.24 Million
25,128
25,128 $2.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Abbot Financial Management, Inc. Portfolio

Follow Abbot Financial Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbot Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abbot Financial Management, Inc. with notifications on news.